APOE and pancreatic ductal adenocarcinoma: In pancreatic ductal adenocarcinoma (PDA) patients, elevated plasma APOE protein levels are associated with poor survival, whereas tumor associated macrophages that are key drivers of immunosuppression are characterized by elevated levels of ApoE in both mouse and human PDA (15).